Clinical Trial Update: Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating venetoclax-based regimens with azacitidine, including combinations with cladribine or chidamide, or alternating VACl/VACh, in adults wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Chidamide (chidamide)
• Cladribine (cladribine)
• Venetoclax (venetoclax)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Myeloid Leukemia, Adult, Newly Diagnosed | Phase 2 | Status: RECRUITING